Literature DB >> 1422260

Immunochemical properties of anti-DNA antibodies in the sera of patients with Escherichia coli bacteremia.

C R Robertson1, D S Pisetsky.   

Abstract

To assess the role of infection in anti-DNA antibody production, the DNA-binding activity of sera from patients with Escherichia coli bacteremia was analyzed. Among 8 patients with bacteremia documented by blood culture, 5 demonstrated increased levels of antibodies to single-stranded DNA from E. coli as measured by enzyme-linked immunosorbent assay. Sera from these patients also reacted with single-stranded DNA from other bacterial and mammalian species as well as certain synthetic polynucleotides including poly-dT and poly-dC. The isotype distribution of these antibodies and their avidity as assessed by competition enzyme-linked immunosorbent assay resembled, moreover, responses of patients with systemic lupus erythematosus. These results suggest that, during the course of infection with E. coli, some patients may produce antibodies with immunochemical properties similar to those arising in systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422260     DOI: 10.1159/000236204

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  Is there a link between Escherichia coli septicemia and the onset of systemic lupus erythematosus? Comment on: overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report (Rheumatol Int. 2011 May; 31(5):695-698).

Authors:  Se Jin Park; Ji Hong Kim; Tae Sun Ha; Jae Il Shin
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 3.  Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens.

Authors:  Connie C Qiu; Roberto Caricchio; Stefania Gallucci
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.